Skip To Main Content
Yang JC on Muck Rack

Yang JC

As seen in: Wiley Clinical Healthcare Hub, Cancer Discovery
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Yang JC’s profile

Articles by Yang JC

Management considerations for adjunct hormone therapy in prostate cancer

|
By Claire Thompson, Julia Murray, Yang JC, Gao AC
| Wiley Clinical Healthcare Hub
Prostate cancer is the second most common cancer in men worldwide and the most common cancer in men in the UK, with 52 300 new cancers diagnosed every year.1 Incidence rates are rising and this is projected to continue with a predicted rise of 15% over the next 15 years. In contrast, the number of patients dying from prostate cancer has fallen by 10% over the last decade to 2019, with now around 12 000 prostate cancer deaths per year in the UK, and is expected to continue to fall.
Open in Who Shared Issue with article?

Translocation of gut microbes to epididymal white adipose tissue drives lipid metabolism disorder under heat stress

|
By Deng ZC, Yang JC, Huang YX, Xu QB
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (613) Issue with article?

Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in Asia

|
By Yang JC, Pietanza MC
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (617) Issue with article?

Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens

|
By Yang JC, Parikh AY, Hanada KI, Rosenberg SA
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (639) Issue with article?

Modifiable Post-Mastectomy Radiation Therapy Factors and Impact on Implant-Based Breast Reconstruction Outcomes

|
By Barnes LL, Yang JC
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (532) Issue with article?

Next-Generation Approaches to Immuno-Oncology in GI Cancers

|
By Hecht JR, Morelli MP, Yang JC
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (630) Issue with article?

Case Report: A tortuous diagnosis and successful multimodal treatment of thyroid follicular carcinoma with pelvic metastasis

|
By Hong ZL, Huang HJ, Yang JC, Wu SS
| ncbi.nlm.nih.gov
Skip to main page content Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software Case Reports doi: 10.3389/fonc.2023.1048485.
Open in Who Shared Issue with article?

TROPION-Lung08: Phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC

|
By Yang JC, Levy BP
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (633) Issue with article?

HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC

|
By Yu HA, Yang JC, Fan PD, Sternberg DW
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (634) Issue with article?

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment - PubMed

|
By Yang JC, Evans CP, Van Dyke JE, Chen HW
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (655) Issue with article?

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer

|
By Rudin CM, Johnson ML, Yang JC, Hann CL
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (652) Issue with article?

[Influencing factors of mild cognitive impairment among the Chinese elderly: a meta-analysis]

|
By Yang JC, Zhang YF, Zhang HX, Qu YM
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (620) Issue with article?

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial | Cancer Discovery

|
By Sequist LV, Yang JC, O'Byrne K, Lim SW
| Cancer Discovery Verified
Research Articles Gregory J. Riely, Joel W. Neal, D. Ross Camidge, Alexander I. Spira, Zofia Piotrowska, Daniel B. Costa, Anne S. Tsao, Jyoti D. Patel, Shirish M. Gadgeel, Lyudmila Bazhenova, Viola W. Zhu, Howard L. West, Tarek Mekhail, Ryan D. Gentzler, Danny Nguyen, Sylvie Vincent, Steven Zhang, Jianchang Lin, Veronica Bunn, Shu Jin, Shuanglian Li and Pasi A.
Open in Who Shared Issue with article?

Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer

|
By Sequist LV, Yang JC, O'Byrne K
| Cancer Discovery Verified
Research Articles Francois Gonzalvez, Sylvie Vincent, Theresa E. Baker, Alexandra E. Gould, Shuai Li, Scott D. Wardwell, Sara Nadworny, Yaoyu Ning, Sen Zhang, Wei-Sheng Huang, Yongbo Hu, Feng Li, Matthew T. Greenfield, Stephan G. Zech, Biplab Das, Narayana I. Narasimhan, Tim Clackson, David Dalgarno, William C. Shakespeare, Michael Fitzgerald, Johara Chouitar, Robert J. Griffin, Shengwu Liu, Kwok-kin Wong, Xiaotian Zhu and Victor M.
Open in Who Shared Issue with article?

Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors

|
By O'Byrne K, Sequist LV, Yang JC, Byron SA
| cancerres.aacrjournals.org
Tumor Biology and Immunology Hiroshi Sootome, Hidenori Fujita, Kenjiro Ito, Hiroaki Ochiiwa, Yayoi Fujioka, Kimihiro Ito, Akihiro Miura, Takeshi Sagara, Satoru Ito, Hirokazu Ohsawa, Sachie Otsuki, Kaoru Funabashi, Masakazu Yashiro, Kenichi Matsuo, Kazuhiko Yonekura and Hiroshi Hirai DOI: 10.1158/0008-5472.CAN-19-2568 Published November 2020 Abstract FGFR signaling is deregulated in many human cancers, and FGFR is considered a valid target in FGFR-deregulated tumors.
Open in Who Shared Issue with article?

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer

|
By Zou JX, Yang JC, Borowsky AD, Louie MC
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (596) Issue with article?

LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism

|
By Yang JC, He XY, Sang LJ, Shi CY
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (430) Issue with article?
Show More